Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in ...
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ...
Medical Device Network on MSN1 天
Telix’s prostate cancer imaging agent approved in Brazil
Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer ...
Stockhead on MSN2 天
Health Check: Fantastico! Telix wins Brazilian assent for prostate cancer imaging agent
Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.
AI tool helps predict who will benefit from focal therapy for prostate cancer
A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...
Healio1 天
Urine test may detect aggressive prostate cancer, eliminate need for some biopsies
A home urine test demonstrated high sensitivity for detection of aggressive prostate cancer, according to study findings.The ...
Pharmabiz22 小时
Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands
Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands: Melbourne, Australia Wednesday, March 19, 2025, 12:00 Hrs [IST] Telix, a biopharmaceutical c ...
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage ...
A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...
Morningstar2 天
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in ...
Illuccix® is the first and only PSMA-PET1 prostate cancer imaging agent to receive full regulatory approval in Brazil. Illuccix®, after radiolabeling with 68Ga, is a radioactive diagnostic agent ...
Telix Pharmaceuticals Limited: Illuccix Approved for Prostate Cancer Imaging in Brazil ...
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...